Nonsteroidal anti-inflammatory drugs (NSAIDs) and mammographic density

Breast Cancer Research and Treatment

Volumn 112, Issue 1, 2008, Pages 133-139

  Maskarinec, Gertraud ^a   Urano, Yasuko ^a   Gill, Jasmeet ^a   Kolonel, Laurence N ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Breast cancer; Mammographic density; NSAIDs; Risk

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PREVENTION; CANCER RISK; DENSITY; DRUG USE; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PAIN; PRIORITY JOURNAL; QUESTIONNAIRE; RISK REDUCTION;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; POSTMENOPAUSE; QUESTIONNAIRES; RISK FACTORS;

EID: 52949097264     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9829-8     Document Type: Article

References (31)

1. RE Harris RT Chlebowski RD Jackson 2003 Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative Cancer Res 63 6096 6101
2. H Swede AL Mirand RJ Menezes KB Moysich 2005 Association of regular aspirin use and breast cancer risk Oncology 68 40 47
3. SA Khuder AB Mutgi 2001 Breast cancer and NSAID use: a meta-analysis Br J Cancer 84 1188 1192
4. SF Marshall L Bernstein H Anton-Culver 2005 Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status J Natl Cancer Inst 97 805 812
5. EJ Jacobs MJ Thun CJ Connell 2005 Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort Cancer Epidemiol Biomarkers Prev 14 261 264
6. JK Gill G Maskarinec LR Wilkens MC Pike BE Henderson LN Kolonel 2007 Nonsteroidal anti-inflammatory Drugs (NSAIDs) and breast cancer risk: The Multiethnic Cohort Am J Epidemiol 166 1150 1158
7. B Arun P Goss 2004 The role of COX-2 inhibition in breast cancer treatment and prevention Semin Oncol 31 22 29
8. RN Dubois 2004 Aspirin and breast cancer prevention: the estrogen connection JAMA 291 2488 2489
9. VA McCormack I dos Santo Silva 2006 Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis Cancer Epidemiol Biomarkers Prev 15 1159 1169
10. Teter B, Fuhrman B, Barba M, Muti P (2006) Aspirin use and mammographic density as a marker of breast cancer risk in postmenopausal women (Abstract). Front Cancer Prevent Res 195
11. G Maskarinec AA Franke AE Williams 2004 Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women Cancer Epidemiol Biomarkers Prev 13 1736 1744
12. G Maskarinec I Pagano G Lurie LR Wilkens LN Kolonel 2005 Mammographic Density and Breast Cancer Risk: The Multiethnic Cohort Am J Epidemiol 162 743 752
13. LN Kolonel BE Henderson JH Hankin 2000 A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics Am J Epidemiol 151 346 357
14. JW Byng NF Boyd E Fishell RA Jong MJ Yaffe 1994 The quantitative analysis of mammographic densities Phys Med Biol 39 1629 1638
15. NF Boyd JW Byng RA Jong 1995 Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study J Natl Cancer Inst 87 670 675
16. G Maskarinec Y Takata AA Franke AE Williams SP Murphy 2004 A 2-year soy intervention in premenopausal women does not change mammographic densities J Nutr 134 3089 3094
17. G Maskarinec I Pagano G Lurie LN Kolonel 2006 A longitudinal investigation of mammographic density: the multiethnic cohort Cancer Epidemiol Biomarkers Prev 15 732 739
18. SAS Institute Inc (2004) SAS OnlineDoc 9.1.2. SAS Institute Inc., Cary, NC
19. Y Zhang PF Coogan JR Palmer BL Strom L Rosenberg 2005 Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited Am J Epidemiol 162 165 170
20. KM Egan MJ Stampfer E Giovannucci BA Rosner GA Colditz 1996 Prospective study of regular aspirin use and the risk of breast cancer J Natl Cancer Inst 88 988 993
21. MB Terry MD Gammon FF Zhang 2004 Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk JAMA 291 2433 2440
22. NR Cook IM Lee JM Gaziano 2005 Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial JAMA 294 47 55
23. RN Dubois 2004 Aspirin and breast cancer prevention: the estrogen connection JAMA 291 2488 2489
24. NF Boyd J Stone LJ Martin 2002 The association of breast mitogens with mammographic densities Br J Cancer 87 876 882
25. JJ Noh G Maskarinec I Pagano LW Cheung FZ Stanczyk 2006 Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women Breast 15 20 28
26. RM Tamimi SE Hankinson GA Colditz C Byrne 2005 Endogenous sex hormone levels and mammographic density among postmenopausal women Cancer Epidemiol Biomarkers Prev 14 2641 2647
27. GA Greendale SL Palla G Ursin 2005 The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study Am J Epidemiol 162 826 834
28. CM Rutter MT Mandelson MB Laya DJ Seger S Taplin 2001 Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy JAMA 285 171 176
29. GA Greendale BA Reboussin S Slone C Wasilauskas MC Pike G Ursin 2003 Postmenopausal hormone therapy and change in mammographic density J Natl Cancer Inst 95 30 37
30. NF Boyd JM Rommens K Vogt 2005 Mammographic breast density as an intermediate phenotype for breast cancer Lancet Oncol 6 798 808
31. NF Boyd GS Dite J Stone 2002 Heritability of mammographic density, a risk factor for breast cancer N Engl J Med 347 886 894